These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3207319)

  • 1. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A; Facchini V; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
    Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor markers in uterine cancers].
    Fukasawa I; Kousaka N; Kun Z; Inaba N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 6. Immuno-histological localization of tissue polypeptide antigen (TPA) in gynecological malignancies.
    Ikarashi T; Takeuchi S; Sudo N; Ueda M; Furuya M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2117-20. PubMed ID: 3908587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor-associated markers in malignant lung neoplasms].
    Piancino G; Racca P; Rayneri W; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1986 Jan; 77(1-2):19-25. PubMed ID: 3945411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
    Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
    Lehtovirta P; Viinikka L; Ylikorkala O
    Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
    Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
    Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of the the tumor markers, Ca-125 and tumor-associated trypsin inhibitor in patients with carcinoma of the cervix and uterus].
    Ilić RS; Mihailović D
    Srp Arh Celok Lek; 1992; 120(3-4):97-9. PubMed ID: 1465666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the levels of CA125, CA19-9, and CEA in the cervical mucus helps a diagnosis of cervical adenocarcinomas].
    Fujii S; Konishi I; Nanbu Y; Sagawa N; Nonogaki H; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2193-4. PubMed ID: 3480920
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
    Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers in the diagnosis of pancreatic carcinoma].
    Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
    Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue polypeptide antigen in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M
    Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.